BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33605082)

  • 1. Glyoxal-induced formation of advanced glycation end-products in type 1 collagen decreases both its strength and flexibility in vitro.
    Kitamura KI; Hirayama J; Tabuchi Y; Minami T; Matsubara H; Hattori A; Suzuki N
    J Diabetes Investig; 2021 Sep; 12(9):1555-1559. PubMed ID: 33605082
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kinoshita S; Mera K; Ichikawa H; Shimasaki S; Nagai M; Taga Y; Iijima K; Hattori S; Fujiwara Y; Shirakawa JI; Nagai R
    Oxid Med Cell Longev; 2019; 2019():9073451. PubMed ID: 31583049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro.
    Bulteau AL; Verbeke P; Petropoulos I; Chaffotte AF; Friguet B
    J Biol Chem; 2001 Dec; 276(49):45662-8. PubMed ID: 11559702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyl-L-hydroxyproline - A potent skin anti-ageing active preventing advanced glycation end-product formation in vitro and ex vivo.
    Knoblich C; Dunckelmann K; Krüger A; Küper T; Blatt T; Weise JM
    Int J Cosmet Sci; 2024 Apr; 46(2):297-306. PubMed ID: 38013225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hyperglycemia on bone metabolism and bone matrix in goldfish scales.
    Kitamura KI; Andoh T; Okesaku W; Tazaki Y; Ogai K; Sugitani K; Kobayashi I; Suzuki N; Chen W; Ikegame M; Hattori A
    Comp Biochem Physiol A Mol Integr Physiol; 2017 Jan; 203():152-158. PubMed ID: 27643756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro glycation of an endothelialized and innervated tissue-engineered skin to screen anti-AGE molecules.
    Cadau S; Leoty-Okombi S; Pain S; Bechetoille N; André-Frei V; Berthod F
    Biomaterials; 2015 May; 51():216-225. PubMed ID: 25771012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen structure and mechanical properties.
    Rock CA; Keeney S; Zakharchenko A; Takano H; Spiegel DA; Krieger AM; Ferrari G; Levy RJ
    Acta Biomater; 2021 Mar; 123():275-285. PubMed ID: 33444798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe³⁺: its potential role in prompt recognition of diabetes mellitus auto-antibodies.
    Shahab U; Tabrez S; Khan MS; Akhter F; Khan MS; Saeed M; Ahmad K; Srivastava AK; Ahmad S
    Chem Biol Interact; 2014 Aug; 219():229-40. PubMed ID: 24968179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyoxal-derived advanced glycation end-products, N
    Kang J; Jeong YJ; Ha SK; Lee HH; Lee KW
    Mol Biol Rep; 2023 Mar; 50(3):2511-2520. PubMed ID: 36609749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
    Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
    BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Glyoxal Modification on a Critical Arginine Residue (Arg-31α) of Hemoglobin: Physiological Implications of Advanced Glycated end Product an
    Banerjee S
    Protein Pept Lett; 2020; 27(8):770-781. PubMed ID: 31774041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact glycation end products containing carboxymethyl-lysine and glyoxal lysine dimer obtained from synthetic collagen model peptide.
    Yamada H; Sasaki T; Niwa S; Oishi T; Murata M; Kawakami T; Aimoto S
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5677-80. PubMed ID: 15482946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyoxal induced glycative insult suffered by immunoglobulin G and fibrinogen proteins: A comparative physicochemical characterization to reveal structural perturbations.
    Alouffi S; Shahab U; Khan S; Khan M; Khanam A; Akasha R; Shahanawaz SD; Arif H; Tahir IK; Rehman S; Ahmad S
    Int J Biol Macromol; 2022 Apr; 205():283-296. PubMed ID: 35192903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Nov; (11):3-13. PubMed ID: 22312908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.
    Lopez-Clavijo AF; Duque-Daza CA; Soulby A; Canelon IR; Barrow M; O'Connor PB
    J Am Soc Mass Spectrom; 2014 Dec; 25(12):2125-33. PubMed ID: 25315462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons.
    Niwa H; Takeda A; Wakai M; Miyata T; Yasuda Y; Mitsuma T; Kurokawa K; Sobue G
    Biochem Biophys Res Commun; 1998 Jul; 248(1):93-7. PubMed ID: 9675092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of histone by glyoxal: recognition of glycated histone containing advanced glycation adducts by serum antibodies of type 1 diabetes patients.
    Ansari NA; Chaudhary DK; Dash D
    Glycobiology; 2018 Apr; 28(4):207-213. PubMed ID: 29360983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Glycation End Products, Diabetes, and Bone Strength.
    Yamamoto M; Sugimoto T
    Curr Osteoporos Rep; 2016 Dec; 14(6):320-326. PubMed ID: 27704396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
    Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
    Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.